VivoSim Labs (VIVS) Interest Coverage Ratio (2011 - 2026)
VivoSim Labs (VIVS) posted quarterly Interest Coverage Ratio of 796.75 for Q1 2026, down 9674.14% year-over-year from 8.32 in Q1 2025, and down 3811.32% quarter-over-quarter from 20.37 in Q4 2025.
VivoSim Labs (VIVS) Interest Coverage Ratio (2011 - 2026) Analysis & Trends
VivoSim Labs' Interest Coverage Ratio history runs 16 years deep, the most recent figure standing at 796.75 for Q1 2026.
- In Q1 2026, Interest Coverage Ratio fell 9674.14% year-over-year to 796.75; the TTM figure through Mar 2026 stood at 28.22 (up 97.76% YoY), while the FY2026 annual figure was 3.83, up 14.72% from the prior year.
- Interest Coverage Ratio for Q1 2026 stood at 796.75, down from 20.37 in the prior quarter.
- The five-year high for Interest Coverage Ratio was 8.32 in Q1 2025, with the low at 796.75 in Q1 2026.
- The 5-year median for Interest Coverage Ratio is 26.55 (2022), against an average of 72.07.
- The sharpest annual moves came in 2025 and 2026: Interest Coverage Ratio jumped 135.48% in 2025, then plunged 9674.14% in 2026.
- VivoSim Labs' Interest Coverage Ratio stood at 56.93 in 2022, then soared by 48.29% to 29.44 in 2023, then grew by 8.68% to 26.88 in 2024, then grew by 24.23% to 20.37 in 2025, then tumbled by 3811.32% to 796.75 in 2026.
- Business Quant data shows VIVS's Interest Coverage Ratio at 796.75 in Q1 2026, 20.37 in Q4 2025, and 19.66 in Q3 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Interest Cover (Qtr) |
|---|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 139.13 Bn | 131.28 Bn | 2.84 Bn | - |
| 2 | Regeneron Pharmaceuticals | 85.77 Bn | 77.77 Bn | 3.93 Bn | 117.59 |
| 3 | Argenx Se | 64.64 Bn | 59.46 Bn | 1.37 Bn | - |
| 4 | Moderna | 58.29 Bn | 53.16 Bn | 52.00 Mn | - |
| 5 | BeOne Medicines | 41.92 Bn | 36.82 Bn | 1.53 Bn | 8.18 |
| 6 | Alnylam Pharmaceuticals | 31.58 Bn | 28.28 Bn | 992.69 Mn | 2.82 |
| 7 | BioNTech SE | 28.12 Bn | 9.73 Bn | 668.28 Mn | 76.86 |
| 8 | Insmed | 27.39 Bn | 26.22 Bn | 358.27 Mn | -0.08 |
| 9 | Royalty Pharma | 27.27 Bn | 26.43 Bn | - | 1.42 |
| 10 | VivoSim Labs | 1.49 Mn | 1.49 Mn | - | -689.75 |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | -8.57 |
| Mar 31, 2026 | -796.75 |
| Dec 31, 2025 | -20.37 |
| Sep 30, 2025 | -19.66 |
| Jun 30, 2025 | -21.75 |
| Mar 31, 2025 | 8.32 |
| Dec 31, 2024 | -26.88 |
| Sep 30, 2024 | -20.06 |
| Jun 30, 2024 | -26.05 |
| Mar 31, 2024 | -23.45 |
| Dec 31, 2023 | -29.44 |
| Sep 30, 2023 | -32.66 |
| Jun 30, 2023 | -33.29 |
| Mar 31, 2023 | -61.74 |
| Dec 31, 2022 | -56.93 |
| Sep 30, 2022 | -27.49 |
| Jun 30, 2022 | -26.55 |
| Mar 31, 2022 | -10.45 |
| Dec 31, 2021 | -6.68 |
| Jun 30, 2021 | -3.55 |